Get started
Author

Pablo Avilés

Observed names: Aviles Lucas, Paz, P Avilés, P. Aviles, P. Avilés Lucas
ORCID: 0009-0002-1577-7122
Observed ORCID: 0009-0002-1577-7122
OpenAlex ID: A5058390180
PM01183, a new DNA minor groove covalent binder with potent in vitro and in vivo anti‐tumour activity
2010 · JFM Leal, M Martínez‐Díez, et al. · British Journal of Pharmacology · 164
PDF
Pharmacokinetics-Pharmacodynamics of a Sordarin Derivative (GM 237354) in a Murine Model of Lethal Candidiasis
2000 · P. Aviles, C. Falcoz, et al. · Antimicrobial Agents and Chemotherapy · 25
Magnetic resonance imaging in the evaluation of inflammatory lesions in muscular and soft tissues: an experimental infection model induced by Candida albicans
1999 · J Ruiz–Cabello, B Carrero–González, et al. · Magnetic Resonance Imaging · 14
Correlation between In Vitro and In Vivo Activities of GM 237354, a New Sordarin Derivative, against Candida albicans in an In Vitro Pharmacokinetic-Pharmacodynamic Model and Influence of Protein Binding
2001 · P. Aviles, C. Falcoz, et al. · Antimicrobial Agents and Chemotherapy · 13
Animal Pharmacokinetics and Interspecies Scaling of Sordarin Derivatives following Intravenous Administration
2001 · P. Aviles, A. Pateman, et al. · Antimicrobial Agents and Chemotherapy · 11
222 Lurbinectedin (PM01183): Pharmacokinetics/Pharmacodynamic (PK/PD) Properties in Pancreas, Ovarian and NSCLC Xenografts
2012 · P. Aviles, M.V. Céspedes, et al. · European Journal of Cancer · 3
55 Low, frequent doses of PM060184 induce remarkable in vivo antitumor activity
2014 · P. Aviles, M.J. Guillen, et al. · European Journal of Cancer · 2
223 Lurbinectedin (PM01183) Synergizes with Gemcitabine in NSCLC, Ovarian and Pancreas Tumor Xenografts
2012 · R. Mangues, M.V. Céspedes, et al. · European Journal of Cancer · 2
513 POSTER Pharmacokinetic evaluation of a novel anti-tumor agent, PM01120
2006 · J. Yin, P. Aviles, et al. · European Journal of Cancer Supplements · 2
271 Antitumor effect of zalypsis (PM00104) in a human pancreatic adenocarcinoma orthotopic model
2010 · P. Aviles, M.V. Cespedes, et al. · European Journal of Cancer Supplements · 1
193 POSTER Preclinical evaluation of the marine compound PM00104 within the ITCC pediatric tumor cell line panel in vitro and in vivo
2008 · A. Verschuur, C. Lanvers, et al. · European Journal of Cancer Supplements · 1
Dataset of the results of the half-value layer measurements conducted within the GuideRadPROS project
2026 · Ketelhut, Steffen, Hayo, Zutz, et al. · Zenodo (CERN European Organization for Nuclear Research)
PM54 induces transcriptional collapse across cell-derived and patient-derived cancer models
2026 · Marta Martínez Diez, Ismael Fernández-Miranda, et al. · Molecular Therapy Oncology
Establishing an independent measurement traceability for 60 Co Air Kerma
2026 · N. Cornejo Díaz, C. García Mulas, et al. · Journal of Instrumentation
PDF
Abstract 2981: PM54 targets oncogenic transcriptional networks across multiple cancer types
2026 · Ismael Fernández-Miranda, Javier Robles, et al. · Cancer Research
Abstract 2841: PM54 reshapes the tumor microenvironment to potentiate checkpoint blockade
2026 · Eugenio Bustos-Morán, Daniel Torralba, et al. · Cancer Research
Abstract 5754: PM54 suppresses WNT/β-catenin signaling and synergizes with chemotherapy in gastric cancer models
2026 · Francisco Javier Gutierrez Alvarez, Gema Santamaria, et al. · Cancer Research
220 Lurbinectedin (PM01183): Antineoplastic Activity in Murine and Human Experimental Models
2012 · R. Frapolli, E. Bello, et al. · European Journal of Cancer
221 Lurbinectedin (PM01183) in Combination with Gemcitabine in Patient-Derived, Pancreatic Ductal Adenocarcinoma (PDA) Xenografts
2012 · P.P. López-Casas, M. Hidalgo, et al. · European Journal of Cancer
896 Antitumor Effect of PM01183 in a Patient-Derived Cisplatin-Sensitive and -Resistant Serous Epithelial Ovarian Orthotopic Tumor Model
2012 · A. Villanueva, A. Vidal, et al. · European Journal of Cancer
181 POSTER Evaluation of the marine compound PM02734 against a pediatric tumor cell line panel by ITCC preclinical drug evaluation program
2008 · B. Geoerger, C. Lanvers, et al. · European Journal of Cancer Supplements
514 POSTER Antitumor activity of aplidin® in human neuroblastoma tumors
2006 · H. Sasak, D. LePage, et al. · European Journal of Cancer Supplements
321 Study on adsorption of ET-743 to materials used in intravenous rodent infusion studies
2003 · J. Verbeeck, A. Looszova, et al. · Toxicology Letters
Works count: 23
Citation count: 238
H-index: 5
I10-index: 5
Year
Topic
Type